Health Care & Hospitals This section contains releases covering every aspect of the health care industry, with special focus on hospitals and medical groups. Find information on upcoming medical and health care conferences, along with study results, policy changes, and news of advancements in the field. Also included are announcements of awards won by doctor, surgeons, and other health care providers as well as financial and company information regarding new appointments and partnerships, funding, quarterly reports, and legal news.

Latest

Jun 23, 2018, 13:30 ET One Drop Announces Blood Glucose Prediction and Automated Decision Support

One Drop, a leader in the development of digital therapeutics solutions for people with diabetes, today announced the launch of Blood Glucose...


Jun 23, 2018, 13:01 ET Diabeloop Insulin Delivery System May Significantly Improve Glycemic Control for People with Type 1 Diabetes

New research finds that people with type 1 diabetes (T1D) who used the Diabeloop DBLG1 therapeutic, closed-loop insulin delivery system in a home...


Jun 23, 2018, 12:43 ET Fully Implantable, Continuous Glucose Monitoring Sensor Provided Accuracy for Six Months in Adolescents and Adults with Type 1 Diabetes

When adolescents and adults with type 1 diabetes (T1D) used a new continuous glucose monitoring (CGM) device containing a sensor that can remain...


Jun 23, 2018, 12:43 ET Dual-Hormone, Artificial Pancreas with Insulin and Pramlintide Significantly Improves Glucose Levels, Compared to Insulin-Only Artificial Pancreas

A dual-hormone, artificial pancreas1 delivering rapid insulin and the drug pramlintide improved glucose control and reduced glucose variability in...


Jun 23, 2018, 12:40 ET Omnipod® Hybrid Closed-Loop Insulin Delivery System Significantly Improves Glycemic Control in Adults with Type 1 Diabetes

Adults with type 1 diabetes using the Omnipod hybrid closed-loop system (the Horizon™ Automated Glucose Control System) were studied in a...


Jun 23, 2018, 10:12 ET Tresiba® demonstrated significantly lower A1C and rates of hypoglycaemia versus insulin glargine U-300 in real-world evidence study

Findings from CONFIRM – a large, retrospective real-world evidence (RWE) study comparing the effectiveness of Tresiba® (insulin degludec injection)...


Jun 23, 2018, 10:09 ET Ozempic® provided greater weight reductions for adults with a baseline BMI ≥25kg/m2 than those with lower baseline BMI <25kg/m2, in a SUSTAIN 7 post-hoc analysis

Ozempic® (semaglutide) injection 0.5 mg or 1 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with...


Jun 23, 2018, 10:06 ET Oral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial

Oral semaglutide, an investigational GLP-1 receptor agonist taken as a once-daily tablet, achieved significant reductions in blood sugar versus...


Jun 23, 2018, 10:03 ET One Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics Study

Employer wellness programs that combine laboratory and biometric screening with digital behavioral counseling can significantly reduce employees'...


Jun 23, 2018, 10:00 ET Real-World Evidence Shows Oral INVOKANA® (canagliflozin) Results in Greater Weight Loss and Treatment Adherence Than Injectable GLP-1 Receptor Agonists in Type 2 Diabetes Patients

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new findings from two real-world studies comparing sodium glucose...


Jun 23, 2018, 10:00 ET Fractyl Announces Presentation of Key Scientific Research at ADA 2018 Indicating That Modern Diets Durably Alter Duodenal Lining, Highlighting the Intestine's Role in Type 2 Diabetes and NASH

Fractyl Laboratories Inc. (Fractyl) today announced the presentation of breakthrough research providing the first clear mechanistic link between...


Jun 23, 2018, 10:00 ET New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce Potential of Lilly's Ultra Rapid Lispro in People with Type 1 and Type 2 Diabetes

Eli Lilly and Company's (NYSE: LLY) ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1...


Jun 23, 2018, 10:00 ET Jardiance® reduced risk of kidney disease progression in adults with type 2 diabetes and established cardiovascular (CV) disease independent of control of conventional CV risk factors

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced findings from two new analyses of the landmark EMPA-REG OUTCOME® trial,...


Jun 23, 2018, 09:47 ET Gaumard's Growing Family Takes Center Stage at AWHONN '18

With women's health, obstetric and neonatal nurses taking on ever-greater responsibilities, there's no better time than AWHONN's 2018 annual...


Jun 23, 2018, 08:05 ET Significant blood sugar improvement with Xultophy® 100/3.6 compared to insulin glargine U-100 when used as add-on to oral diabetes medications

Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL provided superior A1C reduction compared to insulin...


Jun 23, 2018, 08:00 ET Two-year Data from ViaCyte's STEP ONE Clinical Trial Presented at ADA 2018

ViaCyte, Inc., a privately-held regenerative medicine company, today announced two-year data from Cohort 1 of the ongoing Safety, Tolerability, and...


Jun 23, 2018, 08:00 ET Investigational Doses of Lilly's Once-Weekly Trulicity® (dulaglutide) Show Promise in Delivering Powerful Efficacy in People with Type 2 Diabetes

Two investigational doses of Lilly's dulaglutide (4.5 mg and 3.0 mg), as well as Trulicity® (dulaglutide) 1.5 mg, provided significantly better...


Jun 23, 2018, 08:00 ET New Data Show Amgen's Repatha® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes

Amgen (NASDAQ:AMGN) today announced new data that show Repatha® (evolocumab) significantly reduced low-density lipoprotein cholesterol (LDL-C) and...


Jun 23, 2018, 06:00 ET Xcode Life Announces the South Asian Genome (SAGE) Project

Xcode Life, an innovative personal genomics company has announced the worldwide launch of the South Asian Genome (SAGE) Project. This is open to...


Jun 22, 2018, 21:24 ET Cellenkos, Inc. Announces Neuroinflammation Research Collaboration with The University of Texas Health Science Center at Houston

Cellenkos™ and The University Of Texas Health Science Center at Houston today announce a research collaboration for application of cord...


Jun 22, 2018, 19:15 ET Revenue Maximization Group Reiterates Its Full Service Offering for Former CareSync Clients

The stunning announcement that CareSync, a Chronic Care Management company, has shuttered its doors has left their clients and patients without the...


Jun 22, 2018, 18:30 ET Digital Technology Consortium Report Provides Window into Future Trends for Digital Marketing Budget, Staffing and Performance Measurement

Pharmaceutical companies are increasingly using digital engagement channels to more effectively communicate with their customers. Unlike many...


Jun 22, 2018, 18:27 ET International Multi-Centre Collaboration Reveals that Cannabigerol Acts Directly on Cannabinoid Receptors CB1 and CB2

Phytoplant Research S.L. participated in a first-ever pioneering collaborative project to investigate the ability of cannabinoid cannabigerol...


Jun 22, 2018, 17:58 ET Muhammad Yasser Darkazally, M.D. is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Internal Medicine in recognition of his role as an Internist at Saint Francis Hospitalists

Muhammad Yasser Darkazally, M.D. is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Internal Medicine in...